Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1504, 2005-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Hib vaccination programme `highly cost-beneficial' in the US
Inpharma, Vol. 1, Iss. 1361, 2002-01 ,pp. :
Access to resources
Recommend
Hib vaccination programme `highly cost-beneficial' in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 386, 2002-01 ,pp. :
Infanrix-HepB/Hib vaccine mix cuts the number of jabs for infants
Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. :
Hep A vaccination not cost effective for patients with chronic hep C
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 265, 2000-01 ,pp. :
Ramipril `highly cost-effective' in Sweden
Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. :